Zhongzhu Healthcare Holding Co.,Ltd Stock Price

Zhongzhu Healthcare Holding Co.,Ltd engages in the research and development, production, and sale of drugs in China. The company offers ophthalmology drugs, including Pearl eye drops, Sodium Cromolyn eye drops, Acyclovir eye drops, Hydroxybenzazole Hydrochloride eye drops, Acyclovir dispersible tablets, and Gatifloxacin tablets; and products related to tumor treatment. It is also involved in production and sales of products of hepatest ultrasonic liver cirrhosis detector, infusion heater, and Moon God whole body gamma knife. In addition, the company develops 1.1-class chemical drug Leonurine (SCM-198) project with the effect of lowering blood lipids and preventing and treating stroke; and genistein capsules for the treatment of osteoporosis. Further, it engages in residential real estate development; business management; hospital investment management; technology promotion and application services; research and experimental development; special equipment manufacturing industry; and financial leasing business. The company was formerly known as Zhongzhu Holding Co., Ltd. and changed its name to Zhongzhu Healthcare Holding Co., Ltd in June 2016. Zhongzhu Healthcare Holding Co.,Ltd was founded in 1970 and is headquartered in Zhuhai, China.